Stockscreener 앱 받기
0.2354
7.07%
-0.0179
시간 외 거래:
.23
-0.0054
-2.29%
전일 마감가:
$0.2533
열려 있는:
$0.2997
하루 거래량:
37.22M
Relative Volume:
1.94
시가총액:
$10.80M
수익:
-
순이익/손실:
$-21.46M
주가수익비율:
-0.093
EPS:
-2.5324
순현금흐름:
$-14.40M
1주 성능:
-5.92%
1개월 성능:
-7.76%
6개월 성능:
+5.70%
1년 성능:
-45.27%
1일 변동 폭
$0.2279
$0.2997
1주일 범위
$0.2279
$0.2997
52주 변동 폭
$0.1628
$0.8632
Theriva Biologics Inc Stock (TOVX) Company Profile
명칭
Theriva Biologics Inc
전화
301 417 4364
주소
9605 Medical Center Drive, Suite 270, Rockville
Compare TOVX vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TOVX
Theriva Biologics Inc
|
0.2354 | 11.62M | 0 | -21.46M | -14.40M | -2.5324 |
VRTX
Vertex Pharmaceuticals Inc
|
522.25 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.23 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.94 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.59 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.46 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Theriva Biologics Inc 주식(TOVX)의 최신 뉴스
Theriva Biologics (TOVX) Secures Approval for VIRAGE2 Clinical T - GuruFocus
Theriva Biologics launches VIRAGE2 metastatic pancreatic trial - TipRanks
Theriva Biologics cleared to start VIRAGE2 trial | TOVX 8-K Filing - Stock Titan
Theriva Biologics receives approval to start VIRAGE2 cancer trial By Investing.com - Investing.com Canada
Theriva wins Spain nod for more frequent VCN-01 dosing in pancreatic cancer trial - Stock Titan
Theriva Biologics (TOVX) Holds Steady Near Support After Modest GainRetracement Entry - dars.gov.et
Form DEF 14A THERIVA BIOLOGICS For: 29 June By Investing.com - Investing.com Nigeria
Theriva Biologics (NYSE American: TOVX) puts large share and warrant proposals to vote - Stock Titan
Enterprise value to EBIT forward of Theriva Biologics, Inc. – AMEX:TOVX - TradingView
Price to book forward of Theriva Biologics, Inc. – AMEX:TOVX - TradingView
Enterprise value to EBIT forward of Theriva Biologics, Inc. – FWB:SFY0 - TradingView
Enterprise value to EBITDA forward of Theriva Biologics, Inc. – FWB:SFY0 - TradingView
Enterprise value to revenue forward of Theriva Biologics, Inc. – FWB:SFY0 - TradingView
Price to sales forward of Theriva Biologics, Inc. – AMEX:TOVX - TradingView
Price to earnings forward of Theriva Biologics, Inc. – FWB:SFY0 - TradingView
Theriva Biologics Company Profile & Introduction - Moomoo
Theriva Biologics, Inc. Actuals & Estimates (AMEX:TOVX) - TradingView
TOVX Forecast — Price Target — Prediction for 2027 - TradingView
Theriva Biologics, Inc. Actuals & Estimates (FWB:SFY0) - TradingView
SFY0 Forecast — Price Target — Prediction for 2027 - TradingView
Theriva Biologics Inc (TOVX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Theriva Biologics (TOVX) Proxy filing Summary - Quartr
Theriva Biologics Inc (TOVX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TOVX Should I Buy - Intellectia AI
Theriva Biologics Inc (TOVX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Theriva Biologics Inc (TOVX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Theriva Biologics (TOVX) asks shareholders to approve share, plan and warrant changes - Stock Titan
Theriva Biologics Inc (TOVX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Theriva Biologics Inc (TOVX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Theriva Biologics Inc (TOVX) Institutional Confidence - TradingKey
Theriva Biologics Inc (TOVX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Theriva Biologics Inc (TOVX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Why is Theriva stock gaining Monday? - MSN
Theriva Biologics (TOVX) Surges Over 26%: Key Levels to Watch After BreakoutCall Resistance - newsline.com
Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention - TechStock²
Theriva Biologics reports survival data from VCN-01 cancer trial - Investing.com
Theriva Biologics highlights promising VCN-01 Phase 1 results - TipRanks
$Theriva Biologics (TOVX.US)$ - Moomoo
Theriva Biologics (NYSE American: TOVX) shares VCN-01 Phase 1 head and neck cancer data - Stock Titan
Small trial: virus-immunotherapy combo linked to longer survival in head and neck cancer - Stock Titan
TOVX Q1 2026 Earnings: Narrower-Than-Expected Loss as Clinical Pipeline AdvancesOperating Margin Analysis - newsline.com
Theriva Biologics Faces Quorum Issue Delaying Warrant Vote - TipRanks
Theriva Biologics (NYSE: TOVX) fails quorum, delays 16.18M-warrant share vote - Stock Titan
MSN Money - MSN
Number of shareholders of Theriva Biologics, Inc. – AMEX:TOVX - TradingView
Theriva Biologics (TOVX) Slides 8% as Stock Tests Key Support at $0.27Dark Pool Sentiment - The Legal Advocate
Theriva Biologics (TOVX) Faces Pressure: Stock Slides 8% as Key Support Levels Are TestedLeveraged ETF Flow - The Legal Advocate
Theriva Biologics (TOVX) Advances 4.99% as Stock Approaches Key Resistance at $0.33McClellan Oscillator - newsline.com
Theriva Biologics (TOVX) Gains Nearly 5% as Stock Attempts to Recover Key Support LevelsAI Trade Signals - The Legal Advocate
TOVXTheriva Biologics Inc Stock Price and Quote - Finviz
Theriva Biologics (TOVX) Slides 5.73% as Price Nears Critical Support at $0.28BPI Reversal - The Legal Advocate
Theriva Biologics Inc (TOVX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
2.48%
자본화:
|
볼륨(24시간):